［1］ BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2018,68(6):394-424.
［2］ SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［3］ AMEDEI A,BENAGIANO M,DELLA BELLA C,et al.Novel immunotherapeutic strategies of gastric cancer treatment［J］.J Biomed Biotechnol,2011,2011:437-348.
［4］ NELSON WJ,DICKINSON DJ,WEIS WI.Roles of cadherins and catenins in cell-cell adhesion and epithelial cell polarity［J］.Prog Mol Biol Transl Sci,2013,116:3-23.
［5］ GAO H,LAN X,LI S,et al.Relationships of MMP-9,E-cadherin,and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer［J］.Tumour Biol,2017,39(5):1010428317698368.
［6］ DAWOUD MM,AIAD H,TAWFIQ EAE,et al.Role of SIX1,EYA2,and E-cadherin in ovarian carcinoma.Evidence on epithelial-mesenchymal transition from an immunohistochemical study［J］.Ann Diagn Pathol,2021,55:151815.
［7］ FERREIRA P,OLIVEIRA MJ,BERALDI E,et al.Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro［J］.Exp Cell Res,2005,310(1):99-104.
［8］ 左婷婷，郑荣寿，曾红梅，等.中国胃癌流行病学现状［J］.中国肿瘤临床，2017,44(1):52-58.
ZUO TT,ZHENG RS,ZENG HM,et al.Epidemiology of stomach cancer in China［J］.Chinese Journal of Clinical Oncology,2017,44(1):52-58.
［9］ HUMAR B,GUILFORD P.Hereditary diffuse gastric cancer:a manifestation of lost cell polarity［J］.Cancer Sci,2009,100(7):1151-1157.
［10］ SEDAGHATI BURKHANI S,SALIMI M.miR-888 and E-Cadherin levels in ductal carcinoma breast cancer as possible cancer-related markers［J］.Genet Test Mol Biomarkers,2022,26(4):184-190.
［11］ LI M,RAO X,CUI Y,et al.The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer［J］.Oncogene,2022,41(6):770-781.
［12］ GRUPP K,MELLING N,BOGOEVSKA V,et al.Expression of ICAM-1,E-cadherin,periostin and midkine in metastases of pancreatic ductal adenocarcinomas［J］.Exp Mol Pathol,2018,104(2):109-113.
［13］ STROMBERG S,BJORKLUND MG,ASPLUND C,et al.A high-throughput strategy for protein profiling in cell microarrays using automated image analysis［J］.Proteomics,2007,7(13):2142-2150.
［14］ TAWFIK OW,KIMLER BF,DAVIS M,et al.Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma［J］.Histopathology,2006,48(3):258-267.
［15］ 曹睿杰，张玲，周敏，等.S100A4、VEGF在非小细胞肺癌中的表达及其相关性的研究 ［J］.临床肺科杂志,2017,22(7):1197-1200.
CAO RJ,ZHANG L,ZHOU M,et al.Correlation analysis of the expression of S100A4 and VEGF in non-small cell lung cancer tissues［J］.Journal of Clinical Pulmonary Medicine,2017,22(7):1197-1200.
［16］ HE LY,ZHANG H,WANG ZK,et al.Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non-small cell lung cancer patients［J］.Eur Rev Med Pharmacol Sci,2016,20(18):3812-3817.
［17］ TORABIZADEH Z,NOSRATI A,SAJADI SARAVI SN,et al.Evaluation of E-cadherin expression in gastric cancer and its correlation with clinicopathologic parameters［J］.Int J Hematol Oncol Stem Cell Res,2017,11(2):158-164.
［18］ JIANG W,LI Y,OU J,et al.Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China［J］.Medicine (Baltimore),2017,96(42):e8155.
［19］ GURZU S,ORLOWSKA J,SUGIMURA H,et al.Immunohistochemical features and staging of early gastric cancer［J］.Arch Med Sci,2017,13(6):1373-1382.
［20］ CAI Y,ZHENG M,ZHAO Z,et al.Expression of Tspan-1 gene in patients with advanced gastric cancer［J］.Oncol Lett,2017,14(3):2996-3000.
［21］ JAYACHANDRAN J,SRINIVASAN H,MANI KP.Molecular mechanism involved in epithelial to mesenchymal transition［J］.Arch Biochem Biophys,2021,710:108984.
［22］ ZHONG C,ZHUANG M,WANG X,et al.12-Lipoxygenase promotes invasion and metastasis of human gastric cancer cells via epithelial-mesenchymal transition［J］.Oncol Lett,2018,16(2):1455-1462.
［23］ YANG Y，YAN T,HAN Q,et al.ZNF326 promotes colorectal cancer epithelial-mesenchymal transition［J］.Pathol Res Pract,2021,225:153554.